Blockade of Y177 and Nuclear Translocation of Bcr-Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells-Reference-Cited by-同舟云学术

Blockade of Y177 and Nuclear Translocation of Bcr-Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells

Published:2017-03-02 Issue:3 Volume:18 Page:537
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Li Qianyin,Huang Zhenglan,Gao Miao,Cao Weixi,Xiao Qin,Luo Hongwei,Feng Wenli

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/3/537/pdf

Reference44 articles.

1. Chronic Myeloid Leukemia

2. Translation of the Philadelphia chromosome into therapy for CML

3. Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes

4. Imatinib mesylate in the treatment of chronic myeloid leukemia: A local experience;Bee;Med. J. Malays.,2006

5. Optimal first-line treatment of chronic myeloid leukemia. How to use imatinib and what role for newer drugs?;Jabbour;Oncology,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The p53 family member p73 in the regulation of cell stress response;Biology Direct;2021-11-08

2. Effect of HSP90AB1 and CC domain interaction on Bcr-Abl protein cytoplasm localization and function in chronic myeloid leukemia cells;Cell Communication and Signaling;2021-07-03

3. AMP‐activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR‐ABL protein in CML cells;Cancer Science;2020-11-16

4. p19INK4d inhibits proliferation and enhances imatinib efficacy through BCR-ABL signaling pathway in chronic myeloid leukemia;Blood Cells, Molecules, and Diseases;2020-11

5. How does the novel T315L mutation of breakpoint cluster region-abelson (BCR-ABL) kinase confer resistance to ponatinib: a comparative molecular dynamics simulation study;Journal of Biomolecular Structure and Dynamics;2019-02-05